First Tracks Biotherapeutics Inc
TRAX | NASDAQ
$45.08
-$0.15 (-0.32%)
At close: Oct 30, 2026, 4:00 PM ET
$45.40
+$0.32 (+0.71%)
Pre-market:
Nov 2, 2026, 7:26 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q1 2025 Mar 31, 2025 |
|---|---|---|---|---|
Cash & Equivalents | 168.02M | 248.47M | 238.2M | 385.37M |
Short-Term Investments | n/a | 37.99M | 73.44M | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | 256K | n/a |
Receivables | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a |
Other Current Assets | 9.73M | 2.95M | 4.76M | -385.37M |
Total Current Assets | 177.75M | 289.4M | 316.4M | n/a |
Property-Plant & Equipment | 5.4M | 1.17M | 13.89M | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5.39M | 1.17M | 14.15M | n/a |
Total Assets | 183.14M | 290.58M | 330.55M | n/a |
Account Payables | 2.55M | 7.5M | 3.11M | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.44M | n/a | 2.08M | n/a |
Other Current Liabilities | 5.49M | 4.86M | n/a | n/a |
Total Current Liabilities | 12.45M | 33.11M | 31.02M | n/a |
Long-Term Debt | n/a | n/a | 12.03M | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | -391.6M |
Total Long-Term Liabilities | 1.9M | n/a | 12.03M | -391.6M |
Total Liabilities | 14.34M | 33.11M | 43.06M | -391.6M |
Total Debt | 4.33M | n/a | 14.11M | n/a |
Book Value | 168.8M | 257.46M | 287.49M | n/a |
Book Value Per Share | 4.77 | 7.41 | 8.27 | n/a |
Common Stock | 35K | n/a | n/a | n/a |
Retained Earnings | -24.58M | n/a | n/a | n/a |
Comprehensive Income | n/a | -146K | -24K | 391.6M |
Shareholders Equity | 168.8M | 257.46M | 287.49M | 391.6M |
Total Investments | n/a | 37.99M | 73.44M | n/a |
Add to Watchlist
Select watchlists to add or remove TRAX